Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.

Mohammadi E, Rafraf M, Farzadi L, Asghari-Jafarabadi M, Sabour S.

Asia Pac J Clin Nutr. 2012;21(4):511-8.

2.

Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management.

Gray B, Steyn F, Davies PS, Vitetta L.

Eur J Clin Nutr. 2013 Dec;67(12):1234-42. doi: 10.1038/ejcn.2013.197. Epub 2013 Oct 16. Review.

PMID:
24129365
3.

The metabolic syndrome in polycystic ovary syndrome.

Essah PA, Nestler JE.

J Endocrinol Invest. 2006 Mar;29(3):270-80. Review.

PMID:
16682845
4.

Dyslipidemia and oxidative stress in PCOS.

Macut D, Bjekić-Macut J, Savić-Radojević A.

Front Horm Res. 2013;40:51-63. doi: 10.1159/000341683. Epub 2012 Oct 18. Review.

PMID:
24002405
5.

Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation.

Thifault E, Cormier H, Bouchard-Mercier A, Rudkowska I, Paradis AM, Garneau V, Ouellette C, Lemieux S, Couture P, Vohl MC.

J Nutrigenet Nutrigenomics. 2013;6(2):73-82. doi: 10.1159/000350744. Epub 2013 May 8. Review.

PMID:
23689286
6.

Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome.

Carmina E.

Front Horm Res. 2013;40:40-50. doi: 10.1159/000341840. Epub 2012 Oct 18. Review.

PMID:
24002404
7.

Adiponectin and polycystic ovary syndrome.

Groth SW.

Biol Res Nurs. 2010 Jul;12(1):62-72. doi: 10.1177/1099800410371824. Epub 2010 May 24. Review.

8.

Functional Lipids in Metabolic Syndrome.

Nagao K, Yanagita T.

J Nutr Sci Vitaminol (Tokyo). 2015;61 Suppl:S159-61. doi: 10.3177/jnsv.61.S159. Review.

9.

The Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Androgen Status in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.

Hajishafiee M, Askari G, Iranj B, Ghiasvand R, Bellissimo N, Totosy de Zepetnek J, Salehi-Abargouei A.

Horm Metab Res. 2016 May;48(5):281-9. doi: 10.1055/s-0042-105288. Epub 2016 Apr 14. Review.

PMID:
27077458
10.

Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.

He C, Lin Z, Robb SW, Ezeamama AE.

Nutrients. 2015 Jun 8;7(6):4555-77. doi: 10.3390/nu7064555. Review.

11.

Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.

Sadeghi A, Djafarian K, Mohammadi H, Shab-Bidar S.

Diabetes Metab Syndr. 2017 Apr - Jun;11(2):157-162. doi: 10.1016/j.dsx.2016.06.025. Epub 2016 Jul 4. Review.

PMID:
27484441
12.

The role of dietary fatty acids in the pathology of metabolic syndrome.

Lottenberg AM, Afonso Mda S, Lavrador MS, Machado RM, Nakandakare ER.

J Nutr Biochem. 2012 Sep;23(9):1027-40. doi: 10.1016/j.jnutbio.2012.03.004. Epub 2012 Jun 27. Review.

PMID:
22749135
13.

Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence.

Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Martínez JA, Moreno-Aliaga MJ.

J Physiol Biochem. 2013 Sep;69(3):633-51. doi: 10.1007/s13105-013-0265-4. Epub 2013 Jun 22. Review.

PMID:
23794360
14.

[Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].

Hagymási K, Reismann P, Rácz K, Tulassay Z.

Orv Hetil. 2009 Nov 29;150(48):2173-81. doi: 10.1556/OH.2009.28749. Review. Hungarian.

PMID:
19923096
15.

Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome.

Pacifico L, Giansanti S, Gallozzi A, Chiesa C.

Mini Rev Med Chem. 2014;14(10):791-804. Review.

PMID:
25307311
17.

Lipid-lowering drugs and circulating adiponectin.

Wanders D, Plaisance EP, Judd RL.

Vitam Horm. 2012;90:341-74. doi: 10.1016/B978-0-12-398313-8.00013-0. Review.

PMID:
23017722
18.

Metabolic syndrome: a brain disease.

Singh RB, Gupta S, Dherange P, De Meester F, Wilczynska A, Alam SE, Pella D, Wilson DW.

Can J Physiol Pharmacol. 2012 Sep;90(9):1171-83. doi: 10.1139/y2012-122. Epub 2012 Aug 22. Review.

PMID:
22913633
19.

The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia.

Schmidt EB, Kristensen SD, De Caterina R, Illingworth DR.

Atherosclerosis. 1993 Nov;103(2):107-21. Review.

PMID:
8292089
20.

Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome.

Robinson LE, Buchholz AC, Mazurak VC.

Appl Physiol Nutr Metab. 2007 Dec;32(6):1008-24. Review.

PMID:
18059573

Supplemental Content

Support Center